Migraine Research Study
If your current migraine treatment doesn't work for you, there may be another option. We are looking for adults who experience migraine attacks to be a part of the Adult Migraine Studies designed to assess a treatment option that may help prevent or improve migraine symptoms and reduce frequency.
*Volunteers will receive study-related care, including the cost of the issued study drug, at no cost. Participants may receive compensation for their time and travel.
Get Started
Migraines are a debilitating disorder that affects approximately 15% of the population. Every aspect of your life can be impacted when you live with migraines.
Migraine attacks are much more than a normal headache: The pain and throbbing can be extremely intense, and migraines often last hours or even days. We are offering Adult Migraine Studies researching the effectiveness of a study drug for adults who experience migraines. If you qualify and choose to participate, you may have access to this treatment option that may help prevent or improve migraine symptoms and frequency.
See If You Qualify For Our Migraine Research Study!
COMPLETE THE QUESTIONNAIRE
You may be eligible to participate if you:
• Are 18 years of age or older
• Have had a diagnosis of Migraines for at least one year, beginning before age 50
• Experience between 4 to 14 migraine attacks per month
*As a migraine research study participant, all study-related care will be provided at no cost to you, including the study drug. Participants may receive compensation for their time and travel
More Research Studies Coming Soon
Screening for Colon Cancer
IBS-C
GERD
Menstrual Migraines
Diabetic Glucometer Device Study
(open to ALL ethnicities)
We will have more studies available. Click below to join the waiting list.
St. Charles Clinical Research
6034 Weldon Spring Parkway
Weldon Spring, Mo. 63304
General Inquiries
Pharmaceutical Study Experience
Abbott
Pfizer
SKK
SERES
Boston Scientific
Allergan
Merck
Biohaven
Techfield
Baxter
Furiex
Salix Pharmaceuticals
Covance
Cubist
Eli Lilly
GlaxoSmithKline
Galen
Iroko
Ironwood
Medicago
Medimmune
Novartis
Novavax
Noven Therapeutics
Seqirus USA
Teva USA
Vanda pharmaceuticals